Patents by Inventor Benjamin J. Feldman

Benjamin J. Feldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11091788
    Abstract: Embodiments of the present disclosure relate to NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Also provided are methods for making the compositions and for detecting and/or measuring analytes with NADP-dependent oxidoreductase compositions.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: August 17, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman
  • Publication number: 20210236028
    Abstract: An analyte sensor and methods and systems related thereto, where at least one or more of a lower portion of a sensor tail substrate, at least one electrode, a sensing element, a membrane, and an optional non-electrochemical functional layer comprise an antimicrobial quality. Asymmetric, double-sided adhesive binders suitable for adhering the analyte sensor to a skin surface comprising a non-woven scrim, a first pressure-sensitive adhesive layer, a second pressure-sensitive adhesive layer. Overbandages comprising a vapor-permeable backing, an aperture to circumferentially surround a sensor housing, a contact adhesive layer, first and second peelable release liners, and a third peelable release liner disposed upon an anchoring adhesive strip of the contact adhesive layer.
    Type: Application
    Filed: May 17, 2019
    Publication date: August 5, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jonathan D. MCCANLESS, Udo HOSS, Benjamin J. FELDMAN, Frank David FUJIMOTO, Steven T. Mitchell
  • Publication number: 20210228128
    Abstract: Changes in lactate concentrations in vivo may be indicative of a number of physiological conditions, among which can be emotional stress events. Sensing systems for emotional stress events may comprise a lactate-responsive sensor adapted for detecting lactate in vivo, and a processor communicatively coupled to the lactate-responsive sensor. The processor is adapted to determine a plurality of lactate concentrations measured by the lactate-responsive sensor over a period of time. The processor is further adapted to correlate a lactate concentration spike, a lactate concentration change, and/or a lactate concentration rate of change to an emotional stress event occurring within the period of time. The systems may exclude data received during designated or specified sleeping times, exercise, or after eating in order to determine a genuine emotional stress event.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 29, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Hyun Cho, Meghan Sullivan Thompson
  • Publication number: 20210219885
    Abstract: Multiple analytes may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using analyte sensors capable of detecting multiple analytes. Certain analyte sensors capable of the detection of multiple analytes may include first and second working electrodes, analyte-responsive active areas disposed on each of the working electrodes, and reference and counter electrodes. Analyte sensors that include multiple working electrodes but do not include reference and counter electrodes can also be used in conjunction with another sensor that contains reference and counter electrodes, such that these electrodes are shared.
    Type: Application
    Filed: December 30, 2020
    Publication date: July 22, 2021
    Inventors: Yi Wang, Hyun Cho, Benjamin J. Feldman, Kuan-Chou Chen, Lam N. Tran, Stephen Oja, Jonathan D. McCanless
  • Publication number: 20210190719
    Abstract: Methods and analyte sensors including a sensor tail comprising at least a first working electrode and a second working electrode that are spaced apart from one another along a length of the sensor tail. A first active area is disposed upon a surface of the first working electrode and a second active area is disposed upon a surface of the second working electrode, the first active area and the second active area being responsive to different analytes. A mass transport limiting membrane is deposited upon the first active area and the second active area by sequential dip coating operations, and the mass transport limiting membrane comprises a bilayer membrane portion overcoating the first active area and a homogeneous membrane portion overcoating the second active area.
    Type: Application
    Filed: January 18, 2021
    Publication date: June 24, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: John V. LaTour, Jonathan D. McCanless, Stephen Oja, Tianmei Ouyang, Kevin Paul Wallis, Benjamin J. Feldman, Udo Hoss, Suyue Qian
  • Publication number: 20210190718
    Abstract: Analyte sensors responsive at low working electrode potentials may comprise an active area upon a surface of a working electrode, wherein the active area comprises a polymer, a redox mediator covalently bonded to the polymer, and at least one analyte-responsive enzyme covalently bonded to the polymer. A specific redox mediator responsive at low potential may have a structure of wherein G is a linking group covalently bonding the redox mediator to the polymer. A mass transport limiting membrane permeable to the analyte may overcoat the active area. In some sensor configurations, the mass transport limiting membrane may comprise a membrane polymer crosslinked with a branched crosslinker comprising three or more crosslinkable groups, such as polyethylene glycol tetraglycidyl ether.
    Type: Application
    Filed: December 23, 2020
    Publication date: June 24, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: John V. LaTour, Jonathan D. McCanless, Stephen Oja, Tianmei Ouyang, Kevin Paul Wallis, Benjamin J. Feldman, Udo Hoss, Suyue Qian
  • Publication number: 20210137431
    Abstract: Methods and analyte sensors including at least a first working electrode having a first active area thereon, and performing a dip coating operation to deposit a bilayer membrane upon the first working electrode and the first active area. The bilayer may include an inner layer having a first membrane polymer and an outer layer having a second membrane polymer, the first membrane polymer and the second membrane polymer differing from one another. The dip coating operation may comprise one or more first dips in a first membrane formulation to form the inner layer of the bilayer membrane and one or more second dips in a second membrane formulation to form the outer layer of the bilayer membrane upon the inner layer.
    Type: Application
    Filed: January 18, 2021
    Publication date: May 13, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Stephen Oja, Tianmei Ouyang, Hyun Cho, Lam N. Tran, Benjamin J. Feldman, Mark K. Sloan, Ashwin Kumar, Namvar Kiaie, Michael R. Love
  • Publication number: 20210059587
    Abstract: Apparatus, methods, and systems for detecting alcohol concentrations of an individual, and in particular in vivo alcohol concentrations of an individual. Alcohol sensing compositions include at least one alcohol-responsive active area comprising a concerted enzyme system having at least a first enzyme and second enzyme capable of acting in concert to facilitate the detection of alcohol. At least one of the enzymes in the concerted enzyme system is a ketoreductase.
    Type: Application
    Filed: August 28, 2020
    Publication date: March 4, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang
  • Publication number: 20210007665
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 14, 2021
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Publication number: 20210007664
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 14, 2021
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Publication number: 20210000416
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 7, 2021
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Publication number: 20210000415
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 7, 2021
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Patent number: 10859525
    Abstract: Provided are sensors for determining the concentration of an analyte in a sample fluid. In certain embodiments, the sensors include conductive particles and exhibit improved uniformity of distribution of one or more sensing chemistry components, increased effective working electrode surface area, and/or reduced entry of interfering components into a sample chamber of the sensor. Methods of using and manufacturing the sensors are also provided.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: December 8, 2020
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang, Suyue Qian
  • Publication number: 20200241015
    Abstract: Creatinine levels may be monitored as a measure of kidney function. Conventionally, blood and/or urine tests are used for this purpose. Analyte sensors capable of monitoring creatinine in vivo may comprise: a sensor tail comprising at least a first working electrode, a creatinine-responsive active area disposed upon a surface of the first working electrode, a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, and an oxygen scavenger located upon the sensor tail in proximity to the creatinine-responsive active area. The creatinine-responsive active area comprises a first electron transfer agent, a first polymer, and an enzyme system comprising multiple enzymes, particularly creatinine amidohydrolase, creatine amidohydrolase, and sarcosine oxidase, that are capable of acting in concert to facilitate detection of creatinine.
    Type: Application
    Filed: September 25, 2019
    Publication date: July 30, 2020
    Applicant: Abbott Diabetes Care inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman, Hyun Cho
  • Publication number: 20200237277
    Abstract: Multiple enzymes may be present in one or more active areas of an electrochemical analyte sensor for detecting one or more different analytes. In particular, an analyte sensor may comprise a sensor tail configured for insertion into a tissue and one or more working electrodes having a glucose-responsive active area and an ethanol-responsive active area to detect glucose and ethanol in vivo.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman, Hyun Cho, Lam N. Tran, Stephen Oja, Mark K. Sloan, Ashwin Kumar, Namvar Kiaie, Michael R. Love
  • Publication number: 20200237276
    Abstract: Multiple enzymes may be present in the active area(s) of an electrochemical sensor to facilitate analysis of one or more analytes. The multiple enzymes may function independently to detect several analytes or in concert to detect a single analyte. One sensor configuration includes a first active area and a second active area, where the first active area has an oxidation-reduction potential that is sufficiently separated from the oxidation-reduction potential of the second active area to allow independent signal production. Some sensor configurations may have an active area overcoated with a multi-component membrane containing two or more different membrane polymers. Sensor configurations having multiple enzymes capable of interacting in concert include those in which a first enzyme converts an analyte into a first product and a second enzyme converts the first product into a second product, thereby generating a signal at a working electrode that is proportional to the analyte concentration.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Stephen Oja, Tianmei Ouyang, Hyun Cho, Lam N. Tran, Benjamin J. Feldman, Mark K. Sloan, Ashwin Kumar, Namvar Kiaie, Michael R. Love
  • Publication number: 20200237275
    Abstract: Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Mark K. Sloan, Ashwin Kumar, Namvar Kiaie, Michael R. Love
  • Publication number: 20200205706
    Abstract: An analyte sensor comprising: an insertion tip configured for insertion below a tissue of a user, the insertion tip comprising: a working electrode comprising a sensing layer disposed thereon and a membrane layer disposed at least partially over the sensing layer; a substrate; and a counter electrode. Wherein a polymer layer comprising at least an immunosuppressant is disposed on an exterior surface of the working electrode, the substrate, or the counter electrode, the polymer layer being separate from the sensing layer and the membrane layer.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu
  • Patent number: 10631768
    Abstract: Generally, embodiments of the invention relate to self-powered analyte determining devices (e.g., electrochemical analyte monitoring systems) that include a working electrode, a counter electrode, and an optional resistance value, where the working electrode includes analyte sensing components and the self-powered analyte determining device spontaneously passes a current directly proportional to analyte concentration in the absence of an external power source. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 28, 2020
    Assignee: Abbott Diabetes Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang
  • Publication number: 20200060592
    Abstract: It can be particularly difficult to measure pH in vivo using current electrochemical sensors due to sensor drift and fouling of the sensor surface. Sensors suitable for measuring pH, particularly in vivo, may comprise: a sensor tail comprising a first working electrode, a second working electrode, and at least one other electrode; a first active portion located upon the first working electrode, the first active portion comprising a substance having pH-dependent oxidation-reduction chemistry; and a second active portion located upon the second working electrode, the second active portion comprising a substance having oxidation-reduction chemistry that is substantially invariant with pH. A difference between a first signal from the first active portion and a second signal from the second active portion may be correlated to a pH value for a fluid.
    Type: Application
    Filed: August 21, 2019
    Publication date: February 27, 2020
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Suyue Qian